Oral Semaglutide Dose-Ranging Trial Completed for Type 2 Diabetes Efficacy and Safety
Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes
Abstract
Oral semaglutide's dose range, escalation, and efficacy were examined in a global Phase 3 trial for Type 2 Diabetes, now completed.